1. Home
  2. TECX vs ACCO Comparison

TECX vs ACCO Comparison

Compare TECX & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$33.18

Market Cap

393.0M

Sector

N/A

ML Signal

N/A

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

N/A

Current Price

$3.63

Market Cap

373.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
ACCO
Founded
2019
1893
Country
United States
United States
Employees
51
N/A
Industry
Publishing
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
373.2M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
TECX
ACCO
Price
$33.18
$3.63
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$80.40
$6.00
AVG Volume (30 Days)
551.2K
608.9K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
N/A
8.26%
EPS Growth
N/A
141.51
EPS
N/A
0.44
Revenue
N/A
$1,524,700,000.00
Revenue This Year
N/A
$5.79
Revenue Next Year
N/A
$4.84
P/E Ratio
N/A
$8.23
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$3.20
52 Week High
$35.99
$4.82

Technical Indicators

Market Signals
Indicator
TECX
ACCO
Relative Strength Index (RSI) 72.19 30.33
Support Level $16.83 $3.34
Resistance Level N/A $3.86
Average True Range (ATR) 2.47 0.13
MACD 1.25 -0.06
Stochastic Oscillator 81.84 20.47

Price Performance

Historical Comparison
TECX
ACCO

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

Share on Social Networks: